Presentation TCT 2016 Debate #1: Should Low bleeding Risk Patients With Atrial Fibrillation Be Offered LAA Closure? Yes As Long As Full Consent Is Provided, Let the Patient Decide! Presenter: David R. Holmes Jr., Josep Rodés-Cabau, David Hildick-Smith October 30, 2016
Presentation TCT 2016 Update on RCTs in FMR, and First Report of the COAPT Roll-in Patients Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Gregg W. Stone October 30, 2016
Presentation TCT 2016 Paravalvular Regurgitation - The Achilles Hell or Problem Solved: Better Assessment of PVL on the Bench - Recommendations by the ISO Cardiac Valves Committee Presenter: Carlos E. Ruiz, Ulrich Steinseifer, Neelakantan Saikrishnan October 30, 2016
Presentation TCT 2016 Aortic Stenosis + Concomitant Disease I. TAVR in Patients With Mitral Regurgitation - Outcomes and Management Strategies (Including MitraClip) Presenter: A. Pieter Kappetein, Allan Schwartz, Marco Barbanti October 30, 2016
Presentation TCT 2016 Debate #1: Should Low Bleeding Risk Patients With Atrial Fibrillation Be Offered LAA Closure? No Chronic Anticoagulation Should be Offered First Presenter: David R. Holmes Jr., Josep Rodés-Cabau, Stefan C. Bertog October 30, 2016
Presentation TCT 2016 Complications After MitraClip: Frequency, Avoidance, and Treatment Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Scott Lim October 30, 2016
Presentation TCT 2016 Paravalvular Regurgitation - The Achilles Heel or Problem Solved: Latest Updates on the Assessment of Paravalvular Regurgitation (Aortic and Mitral) Presenter: Carlos E. Ruiz, Ulrich Steinseifer, Rebecca T. Hahn October 30, 2016
Presentation TCT 2016 Techniques to Achieve >1+ MR After MitraClip: How Often Is This Obtainable? Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Saibal Kar October 30, 2016
Presentation TCT 2016 Symptomatic High-Risk Aortic Regurgitation: Is TAVR A Viable Alternative? Presenter: A. Pieter Kappetein, Allan Schwartz, Hendrik Treede October 30, 2016
Presentation TCT 2016 Pushing the Anatomic Envelope of MitraClip Eligibility: What Are the Limits? Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Hüseyin Ince October 30, 2016
Presentation TCT 2016 Leaflet Thickening, Dysfunction, and Thrombosis: Clinical Perspectives- Are Problems Under-Reported? Are the Changes a Class Effect? Presenter: Carlos E. Ruiz, Ulrich Steinseifer, Raj Makkar October 30, 2016
Presentation TCT 2016 Rationale for and Outcomes of LAA Closure Plus Pulmonary Vein Isolation Presenter: Vivek Y. Reddy, Steven J. Yakubov, Jamil Abdalla Saad October 30, 2016
Presentation TCT 2016 How and When to Use Multiple MitraClips Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Stephan Baldus October 30, 2016
Presentation TCT 2016 Early Clinical Results With the Cardia LAA Occluder (and Future Studies) Presenter: Vivek Y. Reddy, Steven J. Yakubov, Josep Rodés-Cabau October 30, 2016
Presentation TCT 2016 Leaflet Thickening, Dysfunction, and Thrombosis: Latest Recommendations by the ISO Cardiac Valves Committee Presenter: Carlos E. Ruiz, Ulrich Steinseifer October 30, 2016
Presentation TCT 2016 Comments and What I Might Have Done Differently Presenter: Ricardo Lluberas, Jeffrey W. Moses, Jamil Abdalla Saad, Jose Armando Mangione October 30, 2016
Presentation TCT 2016 Predictors of MitraClip Outcomes: TRAMI and GRASP-IT Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Davide Capodanno October 30, 2016
Presentation TCT 2016 Moderate Aortic Stenosis + Heart Failure: Introduction to the UNLOAD Trial Presenter: A. Pieter Kappetein, Allan Schwartz, Martin B. Leon October 30, 2016
Presentation TCT 2016 Early and Late Results With the LAmbre LAA Occluder (and Future Studies) Presenter: Vivek Y. Reddy, Steven J. Yakubov, Yat-Yin Lam October 30, 2016
Presentation TCT 2016 Case 4: A Patient With Severe Aortic Valve Stenosis and Intermediate Surgical Risk. How Did I Treat It? Presenter: Ricardo Lluberas, Jeffrey W. Moses, Jamil Abdalla Saad, Antonio Enrique Dager October 30, 2016